InfuSystem Q2 net revenue $33.7M (record), net income $0.7M (+65% YoY); reaffirms FY24 high-single-digit growth

InfuSystem Holdings, Inc

2024-Q2 EPS reported -$0.02 revenue$65,693,000

Net revenues $33.7M (+6% YoY); net income $0.7M ($0.03 diluted EPS) vs $0.4M ($0.02) prior year.
Patient Services rev $20.2M (+5%), Device Solutions $13.5M (+8%); overall gross margin 49.5% (down 0.4%).
Adjusted EBITDA $6.1M (18.0% margin), up 5.4% YoY; operating cash flow $2.7M (+17%).
Device Solutions gross margin fell 8.1% to 24.0% due to $0.6M error correction and unfavorable mix.
Reaffirmed FY24 guidance: high-single-digit revenue growth, Adjusted EBITDA margin in high-teens.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.